TD Waterhouse Canada Inc. Increases Stake in CVS Health Corporation $CVS

TD Waterhouse Canada Inc. grew its stake in CVS Health Corporation (NYSE:CVS) by 43.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 452,488 shares of the pharmacy operator’s stock after purchasing an additional 136,033 shares during the period. TD Waterhouse Canada Inc.’s holdings in CVS Health were worth $47,448,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC grew its position in CVS Health by 274.0% during the second quarter. Concurrent Investment Advisors LLC now owns 113,425 shares of the pharmacy operator’s stock valued at $11,734,000 after buying an additional 83,094 shares during the period. NEOS Investment Management LLC raised its position in shares of CVS Health by 12.9% in the second quarter. NEOS Investment Management LLC now owns 206,750 shares of the pharmacy operator’s stock worth $21,388,000 after acquiring an additional 23,637 shares during the period. Mason & Associates Inc purchased a new stake in shares of CVS Health during the 2nd quarter worth about $259,000. iSAM Funds UK Ltd acquired a new stake in shares of CVS Health during the 2nd quarter valued at about $372,000. Finally, Strengthening Families & Communities LLC increased its stake in shares of CVS Health by 0.8% in the 2nd quarter. Strengthening Families & Communities LLC now owns 30,462 shares of the pharmacy operator’s stock valued at $3,151,000 after purchasing an additional 256 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have commented on CVS shares. TD Cowen raised their price objective on CVS Health from $105.00 to $110.00 and gave the company a “buy” rating in a report on Monday, May 11th. Deutsche Bank Aktiengesellschaft increased their target price on CVS Health from $88.00 to $92.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Truist Financial increased their price objective on shares of CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. UBS Group dropped their price objective on shares of CVS Health from $126.00 to $118.00 and set a “buy” rating for the company in a research note on Thursday. Finally, Wells Fargo & Company raised their target price on shares of CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. Twenty-two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $106.83.

CVS Health Stock Down 0.1%

NYSE CVS opened at $97.14 on Friday. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68. The business’s fifty day simple moving average is $100.94 and its 200-day simple moving average is $90.09. The firm has a market cap of $124.24 billion, a PE ratio of 25.70, a P/E/G ratio of 0.95 and a beta of 0.59.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. The company had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. CVS Health’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.7%. CVS Health’s dividend payout ratio (DPR) is 70.37%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.